Treatment for experimental autoimmune neuritis with clodronate (Bonefos)

Immunologic Research

Volumn 56, Issue 2-3, 2013, Pages 334-340

  Katzav, Aviva ^a   Bina, Hofit ^b   Aronovich, Ramona ^b   Chapman, Joab ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Bisphosphonates; Experimental autoimmune neuritis; Gullain Barre syndrome; Inflammation; Macrophages

Indexed keywords

CLODRONIC ACID; GELATINASE B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE NEURITIS; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG DOSE REGIMEN; DRUG MEGADOSE; FEMALE; LOW DRUG DOSE; MOTOR PERFORMANCE; NEURITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ROTAROD TEST; SCIATIC NERVE;

ANIMALS; AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; CLODRONIC ACID; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; HUMANS; MACROPHAGES; MATRIX METALLOPROTEINASE 9; MOTOR ACTIVITY; MYELIN P2 PROTEIN; NEURITIS, AUTOIMMUNE, EXPERIMENTAL; RATS; RATS, INBRED LEW; SCIATIC NERVE; SYNDROME;

EID: 84879555199     PISSN: 0257277X     EISSN: 15590755     Source Type: Journal    
DOI: 10.1007/s12026-013-8406-y     Document Type: Article

References (32)

1. Soffer D, Feldman S, Alter M. Epidemiology of Guillain-Barre syndrome. Neurology. 1978;28:686-90. (Pubitemid 8364274)
2. Kamm C, Zettl UK. Autoimmune disorders affecting both the central and peripheral nervous system. Autoimmun Rev. 2012;11:196-202.
3. Kieseier BC, Lehmann HC, Horste GM. Autoimmune diseases of the peripheral nervous system. Autoimmun Rev. 2012;11:191-5.
4. Israeli E, Agmon-Levin N, Blank M, Chapman J, Shoenfeld Y. Guillain-Barre syndrome-a classical autoimmune disease triggered by infection or vaccination. Clin Rev Allergy Immunol. 2012;42:121-30.
5. Shoenfeld Y, George J, Peter J. Guillain-Barre as an autoimmune disease. Int Arch Allergy Immunol. 1996;109:318-26. (Pubitemid 26082838)
6. Nussinovitch U, Shoenfeld Y. The role of gender and organ specific autoimmunity. Autoimmun Rev. 2012;11:A377-85.
7. Kadlubowski M, Hughes R. Identification of the neuritogen for experimental allergic neuritis. Nature. 1979;277:140-1. (Pubitemid 9093806)
8. Shin H, McFarlane E, Pollard J, Watson E. Induction of experimental allergic neuritis with synthetic peptides from myelin P2 protein. Neurosci Lett. 1989;102:309-12. (Pubitemid 19179809)
9. Waksman N, Adams R. Allergic neuritis: an experimental disease of rabbits induced by the injection of peripheral nervous tissue and adjuvant. J Exp Med. 1955;102:213-25.
10. Aronovich R, Katzav A, Chapman J. The strategies used for treatment of experimental autoimmune neuritis (EAN): a beneficial effect of glatiramer acetate administered intraperitoneally. Clin Rev Allergy Immunol. 2012;42:181-8.
11. Kafri M, Drory V, Wang N, Rabinowitz R, Korczyn A, Chapman J. Assessment of experimental autoimmune neuritis in the rat by electrophysiology of the tail nerve. Muscle Nerve. 2002;25:51-7. (Pubitemid 34019735)
12. Delmas PD. Treatment of postmenopausal osteoporosis. Lancet. 2002;359:2018-26. (Pubitemid 34663722)
13. Ghinoi V, Brandi ML. Clodronate: mechanisms of action on bone remodelling and clinical use in osteometabolic disorders. Expert Opin Pharmacother. 2002;3:1643-56. (Pubitemid 35355894)
14. Prestwood KM, Raisz LG. Prevention and treatment of osteoporosis. Clin Cornerstone. 2002;4:31-41.
15. Schimmer RC, Bauss F. Effect of daily and intermittent use of ibandronate on bone mass and bone turnover in postmenopausal osteoporosis: a review of three phase II studies. Clin Ther. 2003;25:19-34. (Pubitemid 36206736)
16. Benford HL, McGowan NW, Helfrich MH, Nuttall ME, Rogers MJ. Visualization of bisphosphonate-induced caspase-3 activity in apoptotic osteoclasts in vitro. Bone. 2001;28:465-73. (Pubitemid 32409997)
17. Frith JC, Monkkonen J, Auriola S, Monkkonen H, Rogers MJ. The molecular mechanism of action of the antiresorptive and antiinflammatory drug clodronate: evidence for the formation in vivo of a metabolite that inhibits bone resorption and causes osteoclast and macrophage apoptosis. Arthritis Rheum. 2001;44:2201-10. (Pubitemid 33644066)
18. Hughes DE, Wright KR, Uy HL, Sasaki A, Yoneda T, Roodman GD, Mundy GR, Boyce BF. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res. 1995;10:1478-87.
19. Selander KS, Monkkonen J, Karhukorpi EK, Harkonen P, Hannuniemi R, Vaananen HK. Characteristics of clodronate-induced apoptosis in osteoclasts and macrophages. Mol Pharmacol. 1996;50:1127-38. (Pubitemid 26384851)
20. Comi C, Fleetwood T, Dianzani U. The role of T cell apoptosis in nervous system autoimmunity. Autoimmun Rev. 2012;12(2):150-6.
21. Teitelbaum SL, Tondravi MM, Ross FP. Osteoclasts, macrophages, and the molecular mechanisms of bone resorption. J Leukoc Biol. 1997;61:381-8. (Pubitemid 27219830)
22. Udagawa N, Takahashi N, Akatsu T, Tanaka H, Sasaki T, Nishihara T, Koga T, Martin TJ, Suda T. Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc Natl Acad Sci USA. 1990;87:7260-4.
23. Mian M, Benetti D, Aloisi R, Rosini S, Fantozzi R. Effects of bisphosphonate derivatives on macrophage function. Pharmacology. 1994;49:336-42. (Pubitemid 24341014)
24. Makkonen N, Hirvonen MR, Teravainen T, Savolainen K, Monkkonen J. Different effects of three bisphosphonates on nitric oxide production by RAW 264 macrophage-like cells in vitro. J Pharmacol Exp Ther. 1996;277:1097-102. (Pubitemid 27169025)
25. Huitinga I, van Rooijen N, de Groot CJ, Uitdehaag BM, Dijkstra CD. Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J Exp Med. 1990;172:1025-33. (Pubitemid 20343201)
26. Huitinga I, Ruuls SR, Jung S, Van Rooijen N, Hartung HP, Dijkstra CD. Macrophages in T cell line-mediated, demyelinating, and chronic relapsing experimental autoimmune encephalomyelitis in Lewis rats. Clin Exp Immunol. 1995;100:344-51.
27. Tran EH, Hoekstra K, van Rooijen N, Dijkstra CD, Owens T. Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice. J Immunol. 1998;161:3767-75.
28. Jung S, Huitinga I, Schmidt B, Zielasek J, Dijkstra CD, Toyka KV, Hartung HP. Selective elimination of macrophages by dichlormethylene diphosphonate-containing liposomes suppresses experimental autoimmune neuritis. J Neurol Sci. 1993;119:195-202. (Pubitemid 23343059)
29. Kadlubowski M, Hughes R, Gregson N. Experimental allergic neuritis in the Lewis rat: characterization of the activity of peripheral myelin and its major basic protein P2. Brain Res. 1980;184:439-54. (Pubitemid 10187606)
30. McDermott JR, Keith AB. Antigen-induced suppression of experimental allergic neuritis in the guinea pig. J Neurol Sci. 1980;46:137-43. (Pubitemid 10153820)
31. Fux M, van Rooijen N, Owens T. Macrophage-independent T cell infiltration to the site of injury-induced brain inflammation. J Neuroimmunol. 2008;203:64-72.
32. Polfliet MM, van de Veerdonk F, Dopp EA, van Kesteren-Hendrikx EM, van Rooijen N, Dijkstra CD, van den Berg TK. The role of perivascular and meningeal macrophages in experimental allergic encephalomyelitis. J Neuroimmunol. 2002;122:1-8. (Pubitemid 34075485)